Overexpressed PD-L1 on cancer cells binds to PD-1 on tumor-infiltrating lymphocytes (TILs), leading to the inhibition of the TCR signaling cascade [213,214], consequently hindering T cell activation. The gene discussed is CD274; the disease is cancer.